ENBIOSIS Biotechnology

In Nature, one of the most respected scientific journals in the world, it has published that two of the scientific developments that have shaped the last 10 years are microbiome science and artificial intelligence technology.

ENBIOSIS with its staff established by bringing together few and successful names in their field aims to advance microbiome science in order to serve human health and to produce personalized health technologies by targeting new generation artificial intelligence technologies.

2020 Bayer G4A

ENBIOSIS Bıotechnology, became one of the companies eligible to participate in the "Enterprise Acceleration Program" in which Bayer supports initiatives that shape the future.

2020 "Health Initiative of the Year Award"

As Turkey's first and only company in the field we are proud to have taken this award.
-Ömer Özkan, CEO

Scientific Advisory Board

Our Roadmap

We aim to diagnose and treat diseases by balancing human microbiome

plan-yatirimci plan-yatirimci

ENBIOSIS Biotechnology In Global

In addition to providing personalized diet and dietitian services, ENBIOSIS Biotechnology offers artificial intelligence technology to companies that want to provide similar services by positioning as a global platform.

Some of the countries where we provide our technological infrastructure:


Contact Us

If you want to get more information about ENBIOSIS Biotechnology, you can fill out the form. We’ll be in touch as soon as possible.

Websitesini düzgün kullanabilmek için lütfen telefonunuzu dikey modda kullanınız.

Would you like to be aware of us?

You can subscribe to our newsletter to follow up-to-date news about ENBIOSIS and Microbiome.